IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS
Clinical trials for IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI trained on 127,000 ECGs to predict deadly heart rhythms
Knowledge-focused Recruiting nowThis study is not testing a drug or treatment. Instead, researchers are using artificial intelligence to analyze electrocardiogram (ECG) data from over 127,000 people. The goal is to create computer models that can quickly and accurately predict life-threatening heart rhythm prob…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS
Sponsor: Groupe Hospitalier Pitie-Salpetriere • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Massive global registry aims to predict heart damage from cancer therapy
Knowledge-focused Recruiting nowThis study is a worldwide registry that follows 5,000 adults with breast cancer, blood cancers, or those on immune checkpoint inhibitors. Researchers collect medical records, lab results, and imaging to identify who is at risk for heart problems during or after cancer treatment. …
Matched conditions: IMMUNE CHECKPOINT INHIBITOR-RELATED MYOCARDITIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC